Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Katharine Barnard-Kelly, Tadej Battelino, Frank Brosius, Antonio Ceriello, Francesco Cosentino
Kratki znanstveni prispevek
Oznake: cardiovascular disease;chronic kidney disease;diabetes;obesity;person-reported outcomes;
Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
ǂThe ǂuse of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes
Tadej Battelino, Nebojsa M. Lalić, Sufyan Hussain, Antonio Ceriello, Sanja Klobučar, Sarah J Davies, Pinar Topsever, Julie Heverly, Francesca Ulivi
Pregledni znanstveni članek
Oznake: continuous glucose monitoring;consensus statements;intermediate hyperglycemia;obesity;prediabetes;
A global trend towards increased obesity, intermediate hyperglycemia (previously termed prediabetes) and type 2 diabetes, has prompted a range of international initiatives to proactively raise awareness and provide action-driven recommendations to prevent and manage these linked disease states. One ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
ǂA ǂglucose time in range of 70% attenuates the senescence-inducing and pro-inflammatory effects of hyperglycemia
Rosalba La Grotta, Valeria Pellegrini, Francesca Carreras, Cesare Celeste Berra, Karolina Mužina, Barbara Jenko, Klemen Dovč, Francesco Prattichizzo, Tadej Battelino, Antonio Ceriello
Izvirni znanstveni članek
Oznake: continuous glucose monitoring;TIR;TAR;hyperglycemia;inflammation;senescence;endothelial cells;monocytes;type 1 diabetes;PBMC;
Background: The Time In Range (TIR) represents the amount of time spent by a given individual in the range close to normoglycemia, i.e. 70-180 mg/dl. On the basis of studies demonstrating an association of TIR with the incidence of diabetes complications, guidelines recommend a target of at least 70 ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: